Amgen Inc., Gilead Sciences Inc., Novartis AG, Merck & Co., AbbVie Inc. and about two dozen other life sciences organizations and trade associations are creating a coalition to oppose changes to federal antitrust deal review.
The Partnership for the US Life Science Ecosystem, or PULSE, launches Wednesday with 31 members. The group says it will work to raise awareness of the value of mergers and acquisitions in the sector in response to the Federal Trade Commission and Justice Department efforts to crack down on deal activity with new merger guidelines and a revamped disclosure regime.
M&A plays a vital ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.